Itafos (IFOS) Q3 2024 earnings summary

Executive summary

• Q3 2024 Adjusted EBITDA reached $38 million, up 93% year-over-year, with net income of $18.3 million and revenues of $120 million, driven by higher realized prices and improved operational performance at Conda and Arraias.

• Strategic progress included the on-schedule H1/NDR project at Conda, successful refinancing of credit facilities, and an agreement to sell the Araxá project, with closing expected in Q1 2025.

Financial highlights

• Q3 2024 revenues were $120.0 million (vs. $110.8 million in Q3 2023); net income was $18.3 million (vs. $3.1 million); basic EPS was C$0.13 (vs. C$0.02); free cash flow was $(22.4) million (vs. $(21.2) million).

• 9M 2024 revenues were $353.1 million (vs. $346.5 million in 9M 2023); net income was $58.2 million (vs. $51.7 million); basic EPS was C$0.41 (vs. C$0.37); free cash flow was $37.8 million (vs. $36.7 million).

• Trailing 12 months Adjusted EBITDA was $143.5 million; net debt was $39.1 million; net leverage ratio was 0.3x as of September 30, 2024.

• Liquidity stood at $145.3 million, including $65.3 million in cash and $80 million in undrawn borrowing capacity.

Outlook and guidance

• FY 2024 sales volumes projected at 330–340 thousand tonnes P2O5; corporate SG&A expenses of $17–19 million; maintenance capex of $20–30 million; growth capex of $35–45 million.

• Phosphate pricing expected to remain flat through Q4 2024 and into Q1 2025, supported by low inventories, strong demand, and ongoing Chinese export restrictions.